La catena delle opzioni mostra i dati chiave delle opzioni azionarie di IO Biotech a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per IO Biotech..

IO Biotech (NASDAQ:IOBT) Azioni, Catena delle Opzioni

IO BIOTECH INC

IO Biotech

IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.

IO Biotech Inc

Earnings

Press Releases

IO Biotech Reports Second Quarter 2025 Financial Results and Provides Business Highlights

News

Biotech at a Pivotal Moment: Four Stocks Defining The Transformation (MDCX, IOBT, INSM, RNA)

IO Biotech Announces Participation in Upcoming Investor Conferences

Small Cap

Opinion

Innovative Therapeutics Pipeline Positions Industry for Strong Market Growth

Analyst Ratings

IO Biotech Announces Late-Breaking Abstract in Advanced Melanoma Selected for Oral Presentation at ESMO Congress 2025

Penny Stocks

Health Care

IO Biotech Provides Update Following Pre-BLA Meeting with FDA

Clinical Breakthroughs Converge as Immunotherapy Market Surges Past $136 Billion

ARCT

AUTL

CELC

GTBP

INSM

IOBT

LPTX

MAIA

MDCX

SRPT

Akari Therapeutics Plc - American Depositary Shares

Akari Therapeutics

Annovis Bio

AlphaTON Capital

CASI Pharmaceuticals, Inc. - Ordinary Shares

CASI Pharmaceuticals

Dyadic International, Inc. - Common Stock

Dyadic International

Elutia

Evaxion

FibroGen

Generation Bio

Klotho Neurosciences, Inc. - Common Stock

Klotho Neurosciences

Kezar Life Sciences

Liminatus Pharma, Inc. - Class A Common Stock

Liminatus Pharma

Leap Therapeutics

LAVA Therapeutics

Mural Oncology

Neuphoria Therapeutics Inc. - Common Stock

Neuphoria Therapeutics

OnKure Therapeutics, Inc. - Class A Common Stock

OnKure Therapeutics

Pluri

Rein Therapeutics

RenovoRx

Sonnet BioTherapeutics Holdings, Inc. - Common Stock

Sonnet BioTherapeutics

Tenax Therapeutics

Exicure

Xilio Therapeutics

XOMA Royalty Corporation - Depositary Shares Rep Series B 8.375% Cumulative Preferred Stock

XOMA Royalty

8.375% PRF PERPETUAL USD 25 - Ser B 1/1000th

Morgan Stanley

Piper Sandler

Comments

IO Biotech

IO Biotech (IOBT) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO